IBBR is leverages state-of-art integrative methods for bioanalytical, biophysical and structural characterization of biomolecules.
Institute for Bioscience and Biotechnology Research has raised $6.9M in total funding. The most recent round was Grant. The last funding was announced in August 2022.
Institute for Bioscience and Biotechnology Research's investors include National Institute of Allergy and Infectious Diseases.
Institute for Bioscience and Biotechnology Research is headquartered in Rockville, United States.
IBBR is leverages state-of-art integrative methods for bioanalytical, biophysical and structural characterization of biomolecules.
Institute for Bioscience and Biotechnology Research is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Institute for Bioscience and Biotechnology Research — Funding & Investors." VCBacked, August 22, 2022, https://www.vcbacked.co/company/institute-for-bioscience-and-biotechnology-research. Accessed November 13, 2026.
VCBacked. (2022). Institute for Bioscience and Biotechnology Research — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/institute-for-bioscience-and-biotechnology-research
{{cite web |title=Institute for Bioscience and Biotechnology Research — Funding & Investors |url=https://www.vcbacked.co/company/institute-for-bioscience-and-biotechnology-research |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Institute for Bioscience and Biotechnology Research? Request a listing update